Serum VEGF and AT-II were possible contributors to an increased risk of developing ovarian hyperstimulation syndrome(OHSS) in patients with typical PCOS during the early follicular phase (3 hours) afterovarian stimulation (Registration Number: NCT02265861). Here, VEGFA is linked to ovarian hyperstimulation syndrome.